Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology/Urology
Disease Category: Renal Cell Carcinoma

Trial Information

Men and Women ages 18 and over with untreated advanced renal cell carcinoma needed for a research study.

UVa Health System, Department of Medicine, Hematology/Oncology seeks men and women ages 18 and over with untreated advanced renal cell carcinoma for a research study.

The purpose of the study is to learn how effective and safe the drug pazopanib compared to sunitinib is in people with renal cell carcinoma who have received no prior therapy. Study involves possibly taking experimental medication, blood draws and ECGs. Treatment is based upon randomization which consists of taking either oral pazopanib on a daily basis or oral sunitinib on a daily basis for 4 weeks at a time. This study may require up to eleven visits per year with each visit lasting 2-5 hours.

Study-related experimental medication, study related blood draws and ECGs are provided free of charge.

Participants insurance company will be billed for sunitinib, standard of care tests and procedures.

No compensation is provided for this study.

Contact Information:
For more information please contact:
Elaine Dube
Tel: (434)924-9199 Email: ed7y@virginia.edu
IRB-HSR # 14087

Principal Investigator: Christopher Thomas, MD



www.healthsystem.virginia.edu/clinical_trials

Elaine Dube
University of Virginia
School of Medicine
Hematology/Oncology, Internal Medicine
Charlottesville, VA 22908
Phone: 434-924-9199
Fax: --
EMail: ed7y@Virginia.EDU

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.